#14 – Fabrice Paublant: Cooling the Future with Liquid Ventilation
Fabrice Paublant is the Chief Executive Officer at Orixha.
Orixha, a DeepTech company founded in 2018, emerged from a collaboration between researchers and clinicians at Sherbrooke University, EnvA, and INSERM. Dedicated to revolutionizing critical care, Orixha’s mission is to deliver the transformative benefits of liquid ventilation to patients worldwide. The company’s multidisciplinary team, blending expertise in engineering, pathophysiology, and pharmacology, has developed Vent2Cool—the first liquid ventilator designed for intensive care units. Published in leading scientific journals, their work highlights rapid therapeutic hypothermia and anti-inflammatory benefits, particularly for post-cardiac arrest syndrome and acute respiratory distress.